In addition to peptide vaccinations, cellular vaccines using BCR-ABL+ cells could evoke anti-CML immunity by multiple epitopes derived from CML cells [99]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.